Outlook Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell OTLK and other ETFs, options, and stocks.About OTLK
Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of ONS-5010/LYTENAVA. Its pipeline includes unmet patient needs, repackaged IV bevacizumab, and anti-VEGF.
OTLK Key Statistics
Stock Snapshot
The current Outlook Therapeutics(OTLK) stock price is $0.22, with a market capitalization of 27.61M. The stock trades at a price-to-earnings (P/E) ratio of -0.21.
During the trading session on 2026-05-16, Outlook Therapeutics(OTLK) shares reached a daily high of $0.24 and a low of $0.22. At a current price of $0.22, the stock is +1.0% higher than the low and still -7.5% under the high.
Trading volume for Outlook Therapeutics(OTLK) stock has reached 2.65M, versus its average volume of 4.25M.
The stock's 52-week range extends from a low of $0.16 to a high of $3.39.
The stock's 52-week range extends from a low of $0.16 to a high of $3.39.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.